Cargando…

Cardiovascular Toxicity of Androgen Deprivation Therapy

PURPOSE OF REVIEW: Androgen deprivation therapy (ADT) is the standard of care for the treatment of advanced prostate cancer (PC). ADT, particularly with GnRH agonists, leads to increased risk of cardiovascular disease, including myocardial infarction, hypertension, and stroke. This review discusses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boland, Julia, Choi, William, Lee, Maximillian, Lin, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Cardio-Oncology (TG Neilan, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254069/ https://www.ncbi.nlm.nih.gov/pubmed/34216282 http://dx.doi.org/10.1007/s11886-021-01561-9

Ejemplares similares

Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies
por: Stein-Merlob, Ashley F., et al.
Publicado: (2021)

COVID-19 and Cardiovascular Health Among Patients with Cancer
por: Palaskas, Nicolas L., et al.
Publicado: (2020)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2021)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
por: Demissei, Biniyam G., et al.
Publicado: (2020)

CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?
por: Ghosh, Arjun K., et al.
Publicado: (2020)

Palpitations in the Cancer Patient
por: Essa, Hani, et al.
Publicado: (2021)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls
por: Tromp, Jasper, et al.
Publicado: (2020)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Chest Pain in the Cancer Patient
por: Tyebally, Sara, et al.
Publicado: (2022)

Dyspnoea in Oncological Patients: A Brain Teaser
por: Keramida, Kalliopi, et al.
Publicado: (2023)

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
por: Peix, Amalia, et al.
Publicado: (2023)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
por: Blaes, Anne, et al.
Publicado: (2016)

How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations
por: Kambhampati, Swetha, et al.
Publicado: (2023)

Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation‐Associated Cardiovascular Disease and Mortality
por: Camara Planek, Maria Isabel, et al.
Publicado: (2020)

The ESC Working Group on cardiovascular regenerative and reparative medicine
por: Pompilio, Giulio, et al.
Publicado: (2023)

Cardiovascular guidelines based on high-quality evidence: Are we getting there?
por: van Dijk, Wouter B, et al.
Publicado: (2019)

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
por: Huang, Yuhsin Vivian, et al.
Publicado: (2022)

Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
por: Biersmith, Michael A., et al.
Publicado: (2020)

Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology
por: Muhandiramge, Jaidyn, et al.
Publicado: (2022)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019)

Androgen-Deprivation Therapy and Cardiovascular Disease Risk – The Role of Exercise in Prostate Cancer Treatment
por: Wall, Bradley
Publicado: (2016)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Providing next-generation haemodynamic risk prediction through multiscale imaging of cardiovascular pressure gradients: the Horizon Europe MultiPRESS project
por: Marlevi, David
Publicado: (2023)

Are we ready for cell-specific therapies in atherosclerosis?
por: Khan, Abdul Waheed
Publicado: (2023)

Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement
por: Han, Yaling
Publicado: (2022)

Pathophysiology of Demineralization, Part I: Attrition, Erosion, Abfraction, and Noncarious Cervical Lesions
por: Roberts, W. Eugene, et al.
Publicado: (2022)

Pathophysiology of Demineralization, Part II: Enamel White Spots, Cavitated Caries, and Bone Infection
por: Roberts, W. Eugene, et al.
Publicado: (2022)

Massive left atrial thrombus found incidentally in a cancer patient on chronic warfarin therapy treated with enoxaparin
por: Shabbir, Muhammad Asim, et al.
Publicado: (2020)

Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice
por: Chen, Youhu, et al.
Publicado: (2020)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
por: Jacob, Robin, et al.
Publicado: (2021)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0sqjeorjiigdlc15uklo30ig49